chartexchange

GH
Guardant Health, Inc. Common Stock
stockNASDAQ

Market OpenNov 16, 2026 10:39:03 AM EST
145.66USD-3.982%(-6.04)425,139
Pre-marketNov 16, 2026 9:29:30 AM EST
149.13USD-1.694%(-2.57)
145.44Bid146.60Ask1.16Spread
Loading…
Loading…
Healthcare
Diagnostics & Research
HQ
Palo Alto, CA, USA
Previous Close
$151.66
Beta
1.34
52-Week High
$191.05 2026-10-06
52-Week Low
$74.55 2026-04-10
SMA 50
$168.65
SMA 200
$132.79
Avg. Vol 10D
2.78M
Avg. Vol 30D
2.11M
Avg. Vol 90D
2.01M
Relative Vol
0.20
135.29M
129.81M
0.2500%
1,400,000
318
GH Profile

we believe conquering cancer is a big data problem. that's why we built the world's leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we're working on some exciting ones, including in early detection, where the impact on patients can be profound. we've raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.

GH Performance
PeriodPriceDateChangeBeta
1W158.792026-11-09-8.24%0.614
1M158.602026-10-16-8.13%1.685
3M161.672026-08-17-9.88%1.184
6M94.922026-05-15+53.50%1.208
1Y96.482025-11-17+51.02%1.338
2Y29.112024-11-15+400.51%—
5Y105.232021-11-16+38.46%0.637
GH Stock Summary

Guardant Health, Inc. Common Stock (NASDAQ:GH) stock price today is $145.70, and today's volume is 426,304. GH is down 3.955% today. The 30 day average volume is 2.11M. GH market cap is $19.71B with 135.29M shares outstanding.